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An application of 2D-BN nanoparticles as a spectroscopicmarker, weak luminescent marker and anticancer
drug (doxorubicin, DOX) delivery system with protection properties was studied for the LNCaP strains of
cancer cells using FTIR and Raman spectroscopy for analysing the cancer cells, cells with BN, the cancer
cells with DOX, and the cancer cells with BN nanoparticles loaded by DOX. Study of IR absorption and
Raman spectra of the LNCaP strains of cancer cells incubated with 2D-BN nanoparticles for 1 hour
showed that the 2D-BN nanoparticles could pass through the cell membrane and localize inside the
membrane or close to the membrane in the cytoplasm of the cells. We registered the spectra of the
disturbed lipids during the DOX-2D-BN passing through the membrane. After incubation for 2 hours and
more, spectral changes in other structural components of the cell (nuclei, cytoplasm, mitochondria) can
be registered. Confocal microscopy showed that a gold nanostructured support enhances the
ﬂuorescence of the cancer cells with 2D-BN as well as that with DOX, however the double action of 2D-
BN and DOX on the cancer cells aggravates the emission property of the studied system. An MTT test
showed that the toxicity of DOX on the 2D-BN nanoparticles is less than that on the reference cells, and
at the same time the eﬃciency of the DOX action on the cancer cells does not change.Introduction
Despite the signicant progress achieved in the treatment of
various forms of cancer, the problem of acquired resistance of
tumor cells due to the use of chemotherapeutic agents is still
relevant, as is the issue of developing drug delivery systems that
could improve the eﬃciency and specicity of therapeutic
cancer treatment methods.
The possibility of using nanoparticles to solve these prob-
lems has been studied for many years, and the spectrum of the
nanoparticles is the most extensive – from metal (Au, Cd, Fe) to
nonmetallic (Fe2O3, SiO2, TiO2, Al2O3) and carbon (fullerenes,
graphene, nanotubes).1–3 However, these numerous studies did
not lead to signicant progress; many developments still
remain at the stage of laboratory research and are not beingms, Institute of Physics of the National
Nauki 46, Kiev 03039, Ukraine. E-mail:
s of the National Academy of Sciences of
Ukraine
ational Academy of Sciences of Ukraine,
chnical University of Denmark, Denmark.
istry of the National Academy of Sciences
Ukraine
tion (ESI) available. See DOI:
11introduced into clinical practice. The main obstacle is the high
cytotoxicity of nanoparticles, both in relation to tumour cells
and normal healthy cells. When penetrating through cell
membranes, nanoparticles can form complexes with biological
molecules (proteins and DNA, as well as with the cell membrane
itself), thus impeding normal functioning of the biomolecules.
Biological nanoparticles (DNA and RNA molecules, viruses,
enzymes, ribosomes, vesicles etc.) as well as complexes of
organic polymers with medicinal preparations have proven to
be better. But there are limitations associated with the possible
change in the structure of the medication, and therefore the
change in its properties and eﬃcacy in this case.
An active study of graphene has stimulated interest in
research of other kinds of 2D nanomaterials, a unique place
among which is possessed by boron nitride (BN). The unique-
ness of BN monolayer is that it may have a crystal structure
similar to that of graphene, as well as similar physical proper-
ties, with the exception of the band gap width – BN is a typical
dielectric with a band gap of 5 eV. This is due to the ionic
nature of this material. At the same time, its physical properties
and intrinsic luminescence have characteristics similar (close)
to those of diamond nanoparticles.4 The absence of absorption
in the visible range could be one of the advantages of this
material for biological applications.
For example, hexagonal BN, h-BN, in contrast to the above-
mentioned nanoparticles, did not exhibit cytotoxicity to
a number of cell cultures, as shown in several studies. InThis journal is © The Royal Society of Chemistry 2018
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View Article Onlineparticular, BN nanoparticles of 100–200 nm size are not cyto-
toxic to the cell line of osteoblasts,5 while BN nanotubes do not
exhibit cytotoxicity to the neuroblastoma and are able to pene-
trate into the cell via phagocytosis.6,7 Also, attempts to use BN
nanoparticles for the development of drug delivery systems8 and
antitumour therapy9,10 are described literature.11,12
BN is isoelectronic to carbon and can form a number of
allotropic modications – hexagonal graphite-like and cubic
diamond-shaped – according to two types of hybridization – sp2
corresponding to hexagonal and rhombohedral crystal lattices,
and sp3 corresponding to cubic and wurtzite-like ones. The
hexagonal and cubic type of BN lattice are analogues of graphite
and diamond, respectively. During synthesis of 2D-BN nano-
particles by chemical vapor deposition, diﬀerent allotropic
modications can be formed such as amorphous and cubic BN,
additional impurities could be included too. This synthesis
procedure itself requires the use of high temperatures, pres-
sures and signicant energy costs.13–15
In the present paper we propose the use of 2D-BN nano-
particles prepared by liquid exfoliation of the preliminary
solvent-free mechanochemically delaminated bulk h-BN. Our
objective was to study the biophysical properties of the prepared
nanoparticles, to test their cytotoxicity and to analyze their
eﬀect on the cell components, as well as to dene the possibility
of their use as uorescent markers for insertion of non-
luminescent antitumour drugs into the cell that would point
on the location of 2D-BN as well indicate a place of location of
the cell component near the 2D-BN. The aim of the work was
also the visualization of the presence of antitumour drug (e.g.
doxorubicin) in the cells without additional use of dyes and
other uorescent labels. We used infrared spectroscopy to
evaluate molecular interaction of 2D-BN nanoparticles with the
cell components (lipids, proteins, DNA etc.) and Raman spec-
troscopy for visualization of BN nanoparticles inside the cell
indicated on the component cell.
Preparation of 2D-BN nanoparticles
A dry mixture of 50 mg of h-BN (#10043-11-5, Alfa Aesar) and 2 g
of NaCl (#S7653, Aldrich) used as the delamination agent was
mechanochemically treated in an argon atmosphere using an
agate grinding bowl of a planetary ball mill Pulverisette 6
(Fritsch) at a rotation rate of 500 rpm for 1 h. The weight ratio of
reactants to milling media was about 1 : 20. The delamination
agent was removed by washing with water, and the obtained
product – nanostructured h-BN (nh-BN) – was dried in vacuum
at 60 C. The yield of nh-BN was 40 mg.16 The preparation of 2D-
BN was carried out in water by ultrasonic disintegration
(Sonopuls 2070) of nh-BN for 1 h. The resulting dispersions
were puried by centrifugation (5430, Eppendorf) at 2000 rpm
during 1.5 h. 2D-BN nanoparticles were characterized by a series
of mutually complimentary experimental methods and the ob-
tained data are summarized in ESI (Fig. S1–S6†).
Preparation of 2D-BN:DOX
2D-BN:DOX was prepared by mixing 12.5 mL of 2D-BN disper-
sion (0.3 mg mL1) with 5 mL of DOX solution, and 82.5 mL ofThis journal is © The Royal Society of Chemistry 2018phosphate buﬀer, subsequent incubation during for 24 hours,
centrifugation at 5500 rpm for 90min and 10 000 rpm for 1min.
The volume of solution was restored by adding 100 mL of
phosphate buﬀer. We tested optical absorbance at l ¼ 496 nm
with Nanodrop 2000 (ThermoScientic, USA). The DOX optical
absorbance was equal to 0.052 and that of 2D-BN:DOX to 0.019.
For the estimation of cytotoxicity of 2D-BN:DOX (for reference
and cancer cells). Comparative spectral characterization of 2D-
BN and 2D-BN:DOX is shown in Fig. S7 and S8.†
Cell treatment with 2D-BN nanoparticles and sample
preparation for vibrational spectroscopy
To study the eﬀect of 2D-BN nanoparticles on living cells, the
model line of LNCaP tumour cells was used. They were adherent
epithelial cells of adenocarcinoma of human prostate gland,
which are sensitive to androgen. It was believed that LNCaP
reproduce the early stages of prostate cancer development.17
Their approximate size was 10–12 mm in an unattached state,
and it could be larger when attached to the culture surface. The
human prostate adenocarcinoma LNCaP cell line was kindly
provided by Dr V. Kashuba, (Karolinska Institute, Stockholm,
Sweden).
Two sets of experiments were carried out to analyze the eﬀect
of 2D-BN nanoparticles on the LNCaP cells. Within the rst one,
diﬀerent times of the cells incubation with the nanoparticles
(from one to ten hours) were used to detect time dependency,
and the second one was based on one-day incubation. LNCaP
cells were grown in a 6-cup plate in amount of 3  105 cells per
cup (designated as “treated” and “reference” ones), and
cultured under standard conditions (DMEM, 10% FBS, in 5%
CO2 atmosphere). The following day, 2D-BN aqueous dispersion
was added to the cups (the nal concentration in the nutrient
medium was 0.3 mg mL1), and aer the appropriate incuba-
tion time (the nal cell number in the cell was 1  106) the
nutrient medium was removed, washed twice with 1 PBS, and
then the cells were disconnected from the culture plastics
during 5 min by a trypsin–EDTA mixture.
The cells were harvested by centrifugation in 1.5 mL test
tubes at 13 000 rpm for 1 min followed by removal of super-
natant, subsequent double washing with PBS (Sigma-Aldrich)
and drying of the precipitate in vacuum. At the end of the cell
treatment with 2D-BN, each cup of the tablet contained
approximately 1  106 cells (3–4 mg).
2D-BN cytotoxicity assay and visualization of their in-cell
location using dyes
For the cytotoxicity assay of 2D-BN nanoparticles, NIH3T3
mouse culture broblasts (as a model of normal non-tumour
cells) were used. The mouse embryonic broblast NIH3T3 cell
line was kindly provided also by Dr V. Kashuba, (Karolinska
Institute, Stockholm, Sweden).
The cells were scattered in a 96-well plate the day before their
treatment in the amount of 2000 cells per well. An aqueous
solution of 2D-BN was added to achieve a nal concentration of
1, 2, 5, 10, 20, 50 and 100 mg mL1. The cell viability was
measured using the MTT test (Fig. 1) as the percentage of 2D-RSC Adv., 2018, 8, 30404–30411 | 30405
Fig. 1 The vitality of 2D-BN treated NIH3T3 cells.
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View Article OnlineBN-treated live cells against reference cells. Standard deviations
were measured for each three repetitions.
To evaluate the eﬀect of 2D-BN nanoparticles on cytotoxicity
of the anticancer drug doxorubicin (Dox), the NIH3T3 (normal)
or the LNCaP (tumour) cells were dispersed in a 96-well plates
the day before their 2D-BN treatment in amount of 2000 cells
per well. The 2D-BN:Dox complex (with optical absorption of
0.019–0.021) and Dox solution (12.5 mg mL1, optical absorp-
tion 0.020) of equivalent optical absorption were added per
200 mL of cell medium (DMEM) in the following amounts: 3.2,
8, 16 and 32 mL for achieving the nal Dox concentration of 0.2,
0.5, 1 and 2 mg mL1. Cell viability was measured by MTT-test
(Fig. 2) as a percentage of live cells treated with complex 2D-
BN:Dox or pure Dox against reference cells. Standard devia-
tions were measured for each three repetitions.
As could be seen in Fig. 2, 2D-BN does not inhibit the vitality
of NIH3T3 cells, and an increase in its concentration in the
nutrient medium up to 100 mgmL1 did not lead to an increase
in the proportion of dead cells compared to the untreated ones.
Similar studies carried out on the cell treated with 2D-BN:Dox
complex allowed us to found out that addition of 2D-BN:Dox
did not change the viability of the NIH3T3 and the LNCaP
cells compared to the addition of the similar amounts of pure
Dox. This allowed us to conclude that 2D-BN is non-toxic to cells
and does not aﬀect the toxicity of Dox within the prepared 2D-
BN:Dox complexes in accord with Fig. S9.†Fig. 2 The vitality of 2D-BN:Dox treated NIH3T3 (a) and LNCaP (b) cells
30406 | RSC Adv., 2018, 8, 30404–30411Vibrational spectroscopy investigation of 2D-BN nanoparticles
interaction with LNCaP tumour cells
Raman and FTIR measurements. The FTIR spectra were
collected in the 380–5300 cm1 region with an IFS-66 Bruker
instrument. Deconvolution and decomposition of the bands
was performed using Opus-4.0 program.
The Raman spectra of cell were obtained by home-made
Raman instrument with verication of its ability for RS regis-
tration.18 In this study was used two lasers (532 and 785 nm)
with power on sample about 10 mW mm2 at 532 nm and 20
mW mm2 at 785 nm. Dry objective Olympus Plan-Apochromat
40/0.95 in inverted microscope conguration was used. Laser
was focused on the cells placed directly on the CaF2 surface.
Astigmatism-free Princeton Instruments Schmidt-Czerny-
Turner spectrograph IsoPlane SCT-320 was used in our
Raman system. Spectrograph has focal length 320 mm with
aperture ratio f/4.6. Measurements were carried out on grating
with 600 g mm1 (blaze angle at 860 nm), which provide spec-
tral resolution about 5 cm1 in the ranges 100–3800 cm1 from
laser wavelength 532 nm and 2.5 cm1 in the range 200–
1900 cm1 from laser wavelength 785 nm. Spectra were
collected with nitrogen cooled CCD PyLoN 400BR eXcelon
(Princeton Instruments). Wavelength and spectral sensitivity
calibration of the Raman system was done with neon lamp and
calibrated 45 W quartz tungsten halogen lamp (model 63358
from Newport Corp.), respectively. Detailed description of the
Raman system setup was described in (ref. 18). Wavelength
calibration was done automatically during start of the system
soware and aer every switch of gratings in the spectrograph.
Spectral sensitivity calibration was done periodically every
month. For the data analysis we used WiRE3.4 soware.18
Time dependence of 2D-BN nanoparticles interaction with
LNCaP tumour cells. To study the time dependence of 2D-BN
nanoparticles interaction with tumour cells, we have carried
out a set of experiments with diﬀerent times of the cultivation of
the tumour cells treated with nanoparticles. The cells were
cultivated for 1, 2 and 10 h; the reference sample without
nanoparticles was cultivated for 2 h and the corresponding FTIR
data are presented in Fig. 3. The most interesting results were
obtained for the sample aer 1 h cultivation. As one could see
from Fig. 3, upon the 2D-BN treatment, a signicant.
This journal is © The Royal Society of Chemistry 2018
Fig. 3 FTIR absorption spectra of LNCaP cell cultures without (refer-
ence) and after treatment with 2D-BN nanoparticles using 1, 2 and 10 h
incubation time in the region of 2400–3600 cm1.
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View Article Onlineredistribution in the intensity of phospholipid CH3 (the
absorption bands at 2959 and 2871 cm1) and CH2 (the
absorption bands at 2927 and 2853 cm1) groups in favour of
the rst is observed. In the control sample and in the samples
aer 2 and 10 hours of cultivation the absorbance of CH2 groups
was predominating.19–25
Such intensity redistribution suggests an eﬀective interac-
tion of 2D-BN nanoparticles with cell membranes, whereby the
spectral changes take place at the rst hour aer the cell
treatment. In the FTIR spectrum of 2D-BN:LNCaP cells aer 1 h
of cultivation (Fig. 4) some changes in the amide vibration
region are observed consisting in the low-frequency shi of
Amide I maximum from 1654 cm1 in the reference (a-spiral
with signs of disordered form) to 1650 cm1 (a-spiral proteins),
and the shoulder emergence at 1639 cm1 (b-conformation of
proteins).19,20 The shoulder emergence at about 1120 cm1,
which could be attributed to C–O and P–O–C phospholipid
vibration, indicates the interaction of the nanoparticles with the
cell membrane.21–25
Thus, it could be concluded that the 2D-BN nanoparticles
penetrate through the membranes into the cells very fast
(within 1 hour), thereby altering signicantly the cell membrane
structure.Fig. 4 FTIR absorption spectra of LNCaP cell cultures without
(reference) and after treatment with 2D-BN nanoparticles for 1, 2 and
10 h incubation time in the region of 1000–1800 cm1.
This journal is © The Royal Society of Chemistry 2018Study of 2D-BN nanoparticles interaction with LNCaP
tumour cells using Raman spectroscopy. Aer analyzing
a number of micro-Raman spectra of the studied cells, we came
to the conclusion that the position and intensity of the observed
Raman bands essentially depends on the spectrum registration
spot, which could be the cell nucleus, cytoplasm, cellular
organelles (in particular, mitochondria), cell membranes, etc.
When the 2D-BN nanoparticle occurs at the registration spot,
the intensity of the Raman bands increased in 2–5 times, and
the spectrum as a whole was recorded better. This could be due
to reection of the exciting radiation from the nanoparticle and
its subsequent passage through the corresponding cellular
organelle. In other words, the 2D-BN nanoparticles served as
a reecting mirror that multiply directs the excitatory light onto
the cell components. Thus, when the 2D-BN nanoparticle aer
cell treatment is located on the cell membrane, then the regis-
tered Raman spectrumwill be a characteristic of themembrane.
Therefore it is diﬃcult to reproduce these spectra, since it is
diﬃcult to direct the exciting light onto a certain cell organelle.
However, if one choose the right incubation time, it could be
possible to estimate where the nanoparticles would be located.
For example, the Raman spectrum of the LNCaP cell cultures
enhanced by the 2D-BN nanoparticles located near or at the cell
membrane is presented in Fig. 5. The sample was a thick drop
of 2D-BN-treated LNCaP cells suspension at the time of scan-
ning the cells deep into Z axis. It is seen from the gure that the
main contribution to the spectrum is given by lipids and
membrane proteins, with large advantage of the bands from the
lipid fractions, cholesterol in particular. The Raman bands at
616, 1306, 1437, 1605 and 1656 cm1 could be attributed to
lipids, and the band at 1001 cm1 probably refers to free phenyl
alanine.26
Other Raman spectra, which were reproduced with lesser
changes when taken at diﬀerent points of the sample, looked
signicantly diﬀerent as compared to the above mentioned
spectrum (Fig. 6). The band at 1657 cm1 has a complex
structure, since besides lipids and proteins, the DNA of the cell
nucleus could also contribute to this band. This is evidenced by
the appearance of the band at 1338 cm1 and other bands in its
vicinity, assigned to adenine, as well as new band at 780 cm1.Fig. 5 Raman spectra of LNCaP cell cultures after treatment with 2D-
BN nanoparticles (1 day incubation time).
RSC Adv., 2018, 8, 30404–30411 | 30407
Fig. 6 Raman spectra of LNCaP cell cultures without (reference) and
after processing with 2D-BN nanoparticles (1 day incubation time).
Fig. 7 Schematic representation of the cell cytological analysis using
Raman spectroscopy.
Fig. 8 Visualization of LNCaP cells by confocal microscopy: (a) cells
treated with modiﬁed 2D-BN nanoparticles and (b) reference cells
(green ﬂuorescence – FITC, blue ﬂuorescence – Hoechst 33258).
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View Article OnlineThus, we could assume that the place in the cell, from which we
registered this spectrum, is the cell nucleus or the region
nearby.
The Raman band at 1001 cm1 is connected with phenylal-
anine and it is characteristic of the cell protein observed in the
spectrum of any cell. The band at 1657 cm1 is assigned to
Amide I, the band at 1606 cm1 could be attributed to C]C
bonds of amino acids, in particular phenylalanine, as well as
NH2 groups; the band at 1447 cm
1 is probably due to CH2
deformation vibrations of phospholipids.26 With the use of
Raman spectroscopy, it was possible to detect the presence of
2D-BN nanoparticles in the cell, as evidenced by characteristic
1364 cm1 band. In the reference sample (tumour cells without
2D-BN nanoparticles treatment) this band was absent (Fig. 6).
The spectrum of reference cells (without treatment with 2D-
BN nanoparticles) diﬀers from the spectra of the 2D-BN treated
cells by the intensity ratio between the Raman bands (Fig. 7).
Here, the band at 1447 cm1 (CH deformation vibrations) is
the most intense, and the bands at about 1500–1800 cm1
(characteristic bands of proteins and nucleic acid bases) are
weaker, which suggests that the spectrum refers to the cyto-
plasm. In addition, the spectrum of the reference cells is char-
acterized by a higher level of noise and a poorer separation of
the ne structure of the bands.
Thus, using Raman spectroscopy, the spectra from diﬀerent
components of the cell and cellular organelles can be30408 | RSC Adv., 2018, 8, 30404–30411registered. The 2D-BN nanoparticles can enhance the scattering
intensity without distorting the shape and frequency of the
Raman bands. This could be due to dielectric property of 2D-BN
nanoparticles which does not change the dielectric environ-
ment of the cell in contrast to metallic ones.Visualization of FITC-modied 2D-BN nanoparticles in cells
LNCaP cells were grown on 1 cm2 coated glass beads in a 24-cup
plate in an amount of 5  104 cells per cup. The following day,
FITC-modied 2D-BN dispersion (nal concentration in the
nutrient medium was 100 mg mL1) was added to the cups, and
the medium was removed aer 24 h incubation, washed with
PBS, xed with 4% paraformaldehyde, washed 3 times for 5 min
using PBS-T (PBS with 0.2% Triton X-100), stained with a 3258
(Sigma) dye for 5 min, washed with PBS-T, and visualized using
a LSM 510 META (Zeiss) confocal microscope (Fig. 8).
Visualization of cells by confocal microscopy without dyes.
Confocal images27–31 of LNCaP cells grown on diﬀerent
substrates (glass and gold) as well as those treated with the 2D-
BN nanoparticles and Dox are shown in Fig. 9–12. Lumines-
cence confocal images were obtained by a confocal laser scan-
ning microscope Carl Zeiss LSM-510 META with Plan-Neouar
63/0.75 Korr and 40/0.6 Korr objectives. The uorescence
images were registered by using Zeiss AxioCam digital camera.
The PL excitation was carried out using an ultra-violet lamp
HBO 100 and blue (FSet01 wf), green (Fset10 wf), or red (Fset20
wf) lters. It is seen that the cells possess non-specic lumi-
nescence, which is enhanced when the cells are grown on the
gold substrates.
Dox itself demonstrates strong luminescent properties, and
therefore cells treated with Dox are well visualized. In particular,
condensed chromatin of various densities in the form of light
spots is clearly visible in the image of LNCaP cells treated with
Dox. The chromatin condensation process could indicate
necrosis of LNCaP cells provoked by Dox.Discussion
The vibrational spectra of the studied samples showed that 2D-
BN nanoparticles strongly aﬀect the structure of the cellThis journal is © The Royal Society of Chemistry 2018
Fig. 9 Confocal microscopy images of LNCap cell treated with 2D-BN, on glass substrate.
Fig. 10 Confocal microscopy images of LNCap cell treated with 2D-BN, on gold substrate.
Fig. 11 Confocal microscopy images of LNCap cell treated with Dox on gold substrate.
Fig. 12 Confocal microscopy images of LNCap cell treated with Dox
on gold substrate.
This journal is © The Royal Society of Chemistry 2018
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View Article Onlinemembranes incubated for 1 hour. Strong variation in CH
stretching vibrations of the cell membrane in the FTIR spectra,
a signicant reorganization of the Raman spectra of the cells
aer treatment, the confocal microscopy images showing the
presence of the nanoparticles not only on the cell membrane,
but also inside the cells, all conrm the interaction of the
nanoparticles with the cell membrane.
Incubation of the 2D-BN-treated cells during longer periods
of time did not lead to alike changes neither in FTIR or Raman
spectra. That allowed one to suggest that the nanoparticles
penetrate through the cell membrane and localize in the cell
cytoplasm or even near the cell nucleus. The nanoparticles
which do not pass through the membrane may be deposited on
its surface; however this disturbs the cell membrane only
slightly.
Of course, the mechanism of the nanoparticles penetration
through the cell membrane remains unclear yet. We could
assume the phagocytosis mechanism, because we managed toRSC Adv., 2018, 8, 30404–30411 | 30409
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View Article Onlineregister using Raman spectroscopy a strong perturbation of the
cell membrane aer the 2D-BN cell treatment which we believe
could be recorded for strong membrane distortion state and
even at the initial state of the nanoparticle-bearing ball sepa-
ration from the membrane. At this very moment, the lipids in
the examined site of the membrane are strongly disordered,
some of the chemical bonds are broken and new hydrogen
bonds are formed, which was indicated by the increase in the
intensity of the symmetric phosphate absorption bands and the
redistribution of the intensity ratio between the absorption
bands assigned to diﬀerent phosphate groups, as well as
signicant enhancement of intensity of the CH stretching
vibrations (Fig. 3).
According to FTIR spectroscopy, strong membrane pertur-
bation occurred during 1 h incubation. Further cells incubation
did not cause such spectral changes.
Confocal microscopy data showed that the tumour cells
exhibit insignicant level of uorescence without dyes, but
luminescence and contrast of the images increase for cells
being adsorbed on the nanostructured gold surfaces. Labelling
of the cells with 2D-BN nanoparticles enhanced the contrast
under UV excitation and using blue and green lters. When the
red lter was used, the image was barely visible. The uores-
cence of 2D-BN was in the range of 350 nm and absorption of
Dox approximately coincides with the uorescence of gold (540
nm) that could cause an increase in the image contrast. The
incubation of the cells resulted in a much more contrasting
luminescence images in the red lter. More striking lines on the
cell's image most likely referred to places of Dox localization in
the cell. The image became less pronounced upon insertion of
DOX and 2D-BN in the cells. We concluded that DOX and 2D-BN
mutually quench uorescence of each other in the presence of
the gold nanostructured surface, and act collectively to quench
the luminescent cell channels.
Based on the analysis of confocal images, we concluded that
the cell uorescence can be enhanced by using the gold surface.
When the cell was incubated with DOX on the gold surface, the
image obtained with the red lter was amplied. When the cell
was incubated with 2D-BN, the image obtained using blue or
green lter was amplied. When the cells are incubated with
DOX and 2D-BN, the cell uorescence is quenched. These
evidences could indicate the DOX and 2D-BN entering into theFig. 13 Scheme of passing the nanoparticles through the cell
membrane.
30410 | RSC Adv., 2018, 8, 30404–30411cell. Thus, both 2D-BN interaction with the cell and 2D-BN
insertion into the cell could be used for more eﬃcient cell
labelling. The most interesting result here was that 2D-BN
nanoparticles exhibit protective properties against Dox action
on the normal cells when administered together with the
nanoparticles. Meanwhile, the Dox drug eﬀect on the malignant
cells did not change.Conclusions
It was shown that 2D-BN nanoparticles prepared by us do not
exhibit cytotoxicity in relation to normal cells. In a complex with
Dox, the nanoparticles did not change the eﬀectiveness of the
drug eﬀect on the tumour cells.
We were able to register the moment of the tumour cell
membrane perturbation by the 2D-BN nanoparticles using FTIR
and Raman spectroscopy. The analysis of the spectra and
confocal images showed that the nanoparticles pass into the
cells, localize in the cytoplasm and come near the nucleus
(Fig. 13). The details of the interaction of 2D-BN nanoparticles
with the tumour cell components were analysed.
2D-BN nanoparticles, along with the nanostructured golden
surface, can be used to enhance the contrast of the cell images
in confocal microscopy, and can serve as markers to control the
penetration of drugs into the cell, both normal and tumour.
Cells labelled with Dox on the gold nanostructured surface
produce enhanced uorescence images when excited by ultra-
violet light with the red lter.
The cells incubated with DOX and adsorbed on the gold
surface can provide information in confocal microscopy on
whether the DOX interacts with the cell and what changes in the
structure occur there. The features of the luminescent cell
images could be used for analytical purposes.
DOX modied with 2D-BN nanoparticles has the same eﬃ-
ciency on malignant cells as without nanoparticles, but its
protective eﬀect on normal cells increases.
The 2D-BN nanoparticles can be used to enhance the Raman
scattering intensity from the cell components.Conﬂicts of interest
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